Details for: CIST1

Gene ID: 729966

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: CIST1

Ensembl ID: ENSG00000284797

Description: colon, intestine and stomach enriched 1

Cell Significance Landscape

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • foveolar cell of stomach CL0002179
    CSI 6.45
    rCSI 13.72%
    PRS 99.62
  • transit amplifying cell CL0009010
    CSI 5.69
    rCSI 8.71%
    PRS 99.67
  • colon epithelial cell CL0011108
    CSI 4.46
    rCSI 4.68%
    PRS 99.43
  • BEST4+ enteroycte CL4030026
    CSI 4.31
    rCSI 5.36%
    PRS 99.22
  • mucous neck cell CL0000651
    CSI 3.09
    rCSI 4.46%
    PRS 99.49

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [CIST1](/details-gene/729966), an acronym for Colon, Intestine, and Stomach Enriched 1, is a protein-coding gene located on chromosome 19p13.11. As its name suggests, its expression is highly specific to the epithelial lining of the gastrointestinal (GI) tract. **Overall**, it shows the most significant expression in [foveolar cell of stomach](/details-cell/CL0002179), [transit amplifying cell](/details-cell/CL0009010) of the intestine, and [colon epithelial cell](/details-cell/CL0011108). This restricted expression pattern strongly suggests a specialized function in gastric and intestinal homeostasis, potentially related to mucosal barrier function or epithelial cell turnover. ## Cellular Roles and Expression Landscape The expression profile of [CIST1](/details-gene/729966) indicates a highly specialized role within the gastrointestinal epithelium. Its significance is highest in secretory and progenitor cell populations of the stomach and intestines. The most prominent expression is observed in the [foveolar cell of stomach](/details-cell/CL0002179) (CSI: 6.45), which are the mucus-producing surface cells of the stomach lining. This is complemented by significant expression in [mucous neck cell](/details-cell/CL0000651) (CSI: 3.09), reinforcing its potential association with gastric mucus production and the protective barrier. Beyond the stomach, [CIST1](/details-gene/729966) is also a key marker in intestinal cell types. It shows high significance in [colon epithelial cell](/details-cell/CL0011108) (CSI: 4.46) and [BEST4+ enteroycte](/details-cell/CL4030026) (CSI: 4.31), suggesting a role in the function of the large and small intestines. Notably, its strong signal in [transit amplifying cell](/details-cell/CL0009010) (CSI: 5.69), which are rapidly dividing progenitor cells responsible for epithelial renewal, points towards a potential role in the maintenance and regeneration of the gut lining. The collective data portrays [CIST1](/details-gene/729966) as a specific marker of the GI epithelial lineage, with potential functions spanning from mucosal defense to tissue homeostasis. ## Pathways and Molecular Function The precise molecular functions and pathway involvements of [CIST1](/details-gene/729966) are not yet well-characterized in major annotation databases. However, its specific cellular expression landscape allows for functional inference. The high expression in both [foveolar cell of stomach](/details-cell/CL0002179) and [mucous neck cell](/details-cell/CL0000651) strongly suggests an association with the formation and maintenance of the gastric mucosal barrier. Its function may be related to the synthesis, modification, or secretion of mucins or other glycoproteins that form the protective gel layer. Furthermore, its prominent role in [transit amplifying cell](/details-cell/CL0009010) suggests a possible involvement in biological processes critical for epithelial renewal, such as cell cycle regulation, proliferation, or the differentiation of progenitor cells into mature epithelial subtypes. ## Research Directions Future research should focus on elucidating the precise role of [CIST1](/details-gene/729966) in both healthy GI tissue and in pathological conditions such as inflammatory bowel disease (IBD), gastritis, or gastrointestinal cancers, where epithelial barrier function and cell turnover are frequently dysregulated. **Proposed Testable Hypotheses:** 1. **Mucosal Barrier Integrity:** Given its high expression in mucus-producing gastric cells, [CIST1](/details-gene/729966) is hypothesized to be a critical component for the formation or stability of the gastric mucosal barrier. Its absence may lead to increased susceptibility to acid- or pathogen-induced damage. 2. **Epithelial Progenitor Function:** Based on its significance in transit amplifying cells, [CIST1](/details-gene/729966) may regulate the proliferation or differentiation of intestinal stem cell progeny, and its loss could impair the regenerative capacity of the gut epithelium following injury. **Suggested Key Experiments:** To test the hypothesis that [CIST1](/details-gene/729966) is critical for mucosal barrier function, a CRISPR-Cas9-mediated knockout could be generated in a human gastric organoid model system. The impact of [CIST1](/details-gene/729966) deletion on organoid morphology, mucin gene expression (e.g., *MUC5AC*, *MUC6*), and overall barrier integrity (e.g., using a FITC-dextran permeability assay) could be assessed. Furthermore, these knockout organoids could be challenged with *Helicobacter pylori* or acid to determine if they exhibit heightened sensitivity to injury compared to isogenic wild-type controls. **Therapeutic Potential:** The highly restricted expression of [CIST1](/details-gene/729966) within the GI epithelium makes it an attractive potential therapeutic target with a low risk of off-target effects. If it is found to be essential for mucosal barrier function, developing small molecule agonists to enhance its activity could represent a novel therapeutic strategy for conditions characterized by a compromised barrier, such as IBD or stress-induced gastritis. Conversely, if its expression is aberrantly upregulated in certain gastrointestinal cancers, it could serve as a target for antibody-drug conjugates or other targeted inhibition strategies.